Pediatric anesthesia & critical care

Plasma Soluble Intercellular Adhesion Molecule-1 Has a Central Role in Biomarker Network Analysis and Is Associated With Poor Outcomes in Two Distinct Pediatric Cohorts of Acute Respiratory Distress Syndrome and Acute Respiratory Failure

Crit Care MedPublished Secondary analysis of prospective cohort studies

Authors' conclusion

Elevated sICAM-1 levels were associated with poor outcomes in two separate cohorts of ARDS and ARF patients. Network analysis revealed sICAM-1 as a central hub, characterized by high centrality metrics.

Study context

Population
Critically ill children with acute respiratory distress syndrome (ARDS) or acute respiratory failure (ARF) in multicentre PICUstwo cohorts
Participants
214 vs 251
Comparison
Higher vs lower plasma sICAM-1 levels
  • PALIn = 214
  • CAF-PINTn = 251
Primary endpoint
In-hospital mortality
Methodological detailsmulticentre, biomarker network analysis, sICAM-1 measured in plasma collected within 72 hours of diagnosis
  • Multicentre
  • Biomarker network analysis
  • sICAM-1 measured in plasma collected within 72 hours of diagnosis

Primary result

As reported in the abstract

Higher plasma sICAM-1 associated with in-hospital mortality in each cohort
P < 0.05

Secondary outcomes

Multiple organ dysfunction and ventilator-free days (secondary outcomes)

Higher plasma sICAM-1 associated with multiple organ dysfunction and fewer ventilator-free days in each of the two cohorts
all p < 0.05

Biomarker network hubs (composite centrality)

Tissue inhibitor of metalloproteinase-1
0.99
Tumor necrosis factor receptor-1
0.83
sICAM-1
0.74
Interleukin-8
0.74
  • Hubs = centrality metrics in the top 10% (≥ 90th percentile)

Original publication

Plasma Soluble Intercellular Adhesion Molecule-1 Has a Central Role in Biomarker Network Analysis and Is Associated With Poor Outcomes in Two Distinct Pediatric Cohorts of Acute Respiratory Distress Syndrome and Acute Respiratory Failure. Crit Care Med. Published 3 June 2025. doi:10.1097/ccm.0000000000006719

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.